Neutralizing antibody production against Rebif® and ReciGen® in Relapsing-Remitting Multiple Sclerosis (RRMS) patients and its association with patient's disability-Reference-Cited by-同舟云学术

Neutralizing antibody production against Rebif® and ReciGen® in Relapsing-Remitting Multiple Sclerosis (RRMS) patients and its association with patient's disability

Published:2018-09 Issue: Volume:62 Page:109-113
ISSN:1567-5769
Container-title:International Immunopharmacology
language:en
Short-container-title:International Immunopharmacology

Author:

Shokrollahi Barough Mahdieh^ORCID,Ashtari Fereshteh,Sadat Akhavi Mehdi,Asghari Nabiollah,Mosayebi Ghasem,Mirmohammadkhani Majid,Kokhaei Naser,Bahraminia Farhad,Ajami Arman,Kokhaei Parviz^ORCID

Funder

CinnaGen Co

Semnan University

Publisher

Elsevier BV

Subject

Pharmacology,Immunology,Immunology and Allergy

Reference24 articles.

1. Multiple sclerosis: a study of 318 Iranian cases;Aleyasin;Iran. Med.,2002

2. Multiple sclerosis in Iran: a demographic study of 8,000 patients and changes over time;Sahraian;Eur. Neurol.,2010

3. Pathogenesis of multiple sclerosis: insights from molecular and metabolic imaging;Ciccarelli;Lancet Neurol.,2014

4. Immunomodulatory activity of interferon-beta;Kasper;Ann. Clin. Transl. Neurol.,2014

5. Review: neutralizing antibodies against interferon-beta;Sorensen;Ther. Adv. Neurol. Disord.,2008

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antidrug Antibodies Against Biological Treatments for Multiple Sclerosis;CNS Drugs;2022-05-19

2. Types of Interferons and Their Expression in Plant Systems;Journal of Interferon & Cytokine Research;2022-02-01

3. Biosimilars in Treatment of Multiple Sclerosis in Iran;Archives of Iranian Medicine;2021-10-01

4. Aggregation of protein therapeutics enhances their immunogenicity: causes and mitigation strategies;RSC Chemical Biology;2021